| Literature DB >> 33518159 |
Maria Daniela Hurtado A1, Andres Acosta2.
Abstract
The highly variable response to obesity therapies justifies the search for treatment strategies that are best suited to individual patients to enhance their effectiveness and tolerability via precision medicine. Precision medicine development in recent years has been driven by the emergence of powerful methods to characterize patients ("omic" assays). Current available information has revealed that there are numerous intermediary processes that contribute to obesity and have provided a framework for partially comprehending the mechanisms behind the heterogeneity of obesity and its clinical consequences. Some of these processes have or are currently being targeted to individualize obesity therapy with some success.Entities:
Keywords: Nutrigenomics; Obesity; Personalized nutrition; Phenotype; Precision medicine
Mesh:
Year: 2021 PMID: 33518159 PMCID: PMC7863578 DOI: 10.1016/j.gtc.2020.10.005
Source DB: PubMed Journal: Gastroenterol Clin North Am ISSN: 0889-8553 Impact factor: 3.806